Cargando…
In vitro and in vivo characterization of erythrosin B and derivatives against Zika virus
Zika virus (ZIKV) causes significant human diseases without specific therapy. Previously we found erythrosin B, an FDA-approved food additive, inhibited viral NS2B−NS3 interactions, leading to inhibition of ZIKV infection in cell culture. In this study, we performed pharmacokinetic and in vivo studi...
Autores principales: | Li, Zhong, Xu, Jimin, Lang, Yuekun, Wu, Xiangmeng, Hu, Saiyang, Samrat, Subodh Kumar, Tharappel, Anil M., Kuo, Lili, Butler, David, Song, Yongcheng, Zhang, Qing-Yu, Zhou, Jia, Li, Hongmin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279632/ https://www.ncbi.nlm.nih.gov/pubmed/35847519 http://dx.doi.org/10.1016/j.apsb.2021.10.017 |
Ejemplares similares
-
Methylene blue is a potent and broad-spectrum inhibitor against Zika virus in vitro and in vivo
por: Li, Zhong, et al.
Publicado: (2020) -
Prospect of SARS-CoV-2 spike protein: Potential role in vaccine and therapeutic development
por: Samrat, Subodh Kumar, et al.
Publicado: (2020) -
Safety of erythrosine for ornamental fish
por: Bampidis, Vasileios, et al.
Publicado: (2019) -
Antiviral Agents against Flavivirus Protease: Prospect and Future Direction
por: Samrat, Subodh K., et al.
Publicado: (2022) -
Inteins as Drug Targets and Therapeutic Tools
por: Tharappel, Anil Mathew, et al.
Publicado: (2022)